Most Recent Articles by Laura Stiles
Researchers examined whether there are clinical features or treatments associated with neuropsychiatric outcomes in BECTS.
This objective score may have the potential to be an early outpatient screening tool for identifying PNES.
An emerging line of inquiry suggests a potential association between comorbidities and MS relapses, but studies have been limited.
With its 20-minute application time, the BICAMS is one of the few tools available for small centers with only a few staff members who might not be trained in administering neuropsychological tests.
A panel of clinicians from different pediatric fields have developed new guidelines for the treatment of PANS.
More Articles by Laura Stiles
Neurology Advisor Articles
- McDonald Criteria Update: Further Distinction Between Relapsing-Remitting, Primary-Progressive MS
- Diet Linked to Multiple Sclerosis Disability, Disease Severity
- Deep Brain Stimulation Improves Survival in Parkinson Disease
- Guidelines for Cervical, Ocular Vestibular Evoked Myogenic Potential Testing: AAN
- Obesity and Alzheimer Disease: Exploring Risk Modification
- Coffee Consumption May Decrease Stroke Risk
- When and How to Approach Driving Cessation in Patients With Dementia
- Erenumab, Fremanezumab Reduce Migraine Frequency, Burden
- Some Antiepileptic Drugs Associated With Increased Risk for Toxic Epidermal Necrolysis
- Language Deficits and EEG Changes Predict Conversion From MCI to Alzheimer Disease
- Sex Differences in Parkinson Disease: Implications for Diagnosis, Treatment
- Understanding Poststroke Depression: Risk Factors and Treatment
- Value-Based Payment Modifier Program Has Little Effect on Practice Performance
- Growth in Health Care Spending Slowed in 2016
- Paternal Selective Serotonin Reuptake Inhibitor Use Linked to ADHD in Offspring